Format

Send to

Choose Destination
Swiss Med Wkly. 2014 Dec 23;144:w14058. doi: 10.4414/smw.2014.14058. eCollection 2014.

Subclinical hypothyroidism: summary of evidence in 2014.

Author information

1
Department of General Internal Medicine, Inselspital, Bern University Hospital, Switzerland.

Abstract

Subclinical hypothyroidism, which is defined as elevated thyroid-stimulating hormone (TSH) levels with free thyroxine concentrations within the reference range, is a common disorder that increases with age and affects up to 18% of the elderly, with a higher prevalence in women compared to men. Prospective data have shown an increased risk of coronary heart disease events, heart failure, and cardiovascular mortality among affected adults. Conflicting results have been found on the association between subclinical hypothyroidism and cognitive impairment, depression and the risk of fractures. Management strategies including screening and treatment of subclinical hypothyroidism are still controversial, while the ongoing European randomised controlled trial "TRUST" targets to solve these uncertainties. This narrative review aims to assess current evidence on the clinical aspects, as well as screening and treatment recommendations in adults with subclinical hypothyroidism.

PMID:
25536449
DOI:
10.4414/smw.2014.14058
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for EMH Swiss Medical Publishers Ltd.
Loading ...
Support Center